Andrew R Allen

Andrew R Allen

UNVERIFIED PROFILE

Are you Andrew R Allen?   Register this Author

Register author
Andrew R Allen

Andrew R Allen

Publications by authors named "Andrew R Allen"

Are you Andrew R Allen?   Register this Author

7Publications

331Reads

15Profile Views

Rociletinib in EGFR-Mutated Non-Small-Cell Lung Cancer.

N Engl J Med 2015 08;373(6):578-9

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMc1506831DOI Listing
August 2015

Rociletinib in EGFR-mutated non-small-cell lung cancer.

N Engl J Med 2015 Apr;372(18):1700-9

From Massachusetts General Hospital (L.V.S., R.S.H., J.L., Z.P.), Harvard Medical School (L.V.S., G.R.O., R.S.H., Z.P.), and Dana-Farber Cancer Institute (G.R.O.) - all in Boston; the Drug Development Department, Université Paris-Sud, Gustave Roussy Cancer Campus (J.-C.S.), and Institut Gustave Roussy (A.V.), Villejuif - both in France; the David Geffen School of Medicine, University of California, Los Angeles, Los Angeles (J.W.G., E.B.G., M.A.M., S.N.), and Stanford Cancer Institute, Stanford University, Stanford (H.A.W., J.W.N.) - both in California; the Barbara Ann Karmanos Cancer Institute, Wayne State University, Detroit (S.M.G., C.G., A.J.W.); University of Texas M.D. Anderson Cancer Center, Houston (V.P.); the Peter MacCallum Cancer Centre, Melbourne, VIC, Australia (B.J.S.); the Medical University of Gdansk, Gdansk, Poland (R.D.); the University of Colorado (D.L.A., D.R.C.) and University of Colorado Cancer Center (R.C.D.) - both in Aurora; and Clovis Oncology, San Francisco (M.R., C.A.K., S.J.-T., S.L.M., A.R.A.), Boulder, CO (J.I., D.D.), and Cambridge, United Kingdom (L.R.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1413654DOI Listing
April 2015

Blockade of the CD154-CD40 costimulatory pathway prevents the development of experimental autoimmune glomerulonephritis.

Kidney Int 2004 Oct;66(4):1444-52

Renal Section, Division of Medicine, Imperial College London, Hammersmith Hospital, London, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1523-1755.2004.00907.xDOI Listing
October 2004

Blocking VLA-4 prevents progression of experimental crescentic glomerulonephritis.

Nephron Exp Nephrol 2003 ;95(3):e100-10

Renal Section, Faculty of Medicine, Imperial College London, Hammersmith Hospital, London, UK.

View Article

Download full-text PDF

Source
https://www.karger.com/Article/FullText/74326
Publisher Site
http://dx.doi.org/10.1159/000074326DOI Listing
January 2004